| Primary |
| Drug Use For Unknown Indication |
17.8% |
| Helicobacter Infection |
11.8% |
| Pharyngitis |
7.6% |
| Streptococcal Infection |
6.8% |
| Nasopharyngitis |
6.3% |
| Kawasaki's Disease |
6.0% |
| Gastric Ulcer |
5.5% |
| Gastritis |
3.9% |
| Upper Respiratory Tract Inflammation |
3.7% |
| Tonsillitis |
3.4% |
| Hypertension |
3.1% |
| Laryngotracheo Bronchitis |
3.1% |
| Bronchitis Acute |
2.9% |
| Convulsion |
2.9% |
| Pneumonia |
2.9% |
| Bronchitis |
2.6% |
| Cystitis |
2.6% |
| Gastric Ulcer Helicobacter |
2.4% |
| Otitis Media Acute |
2.4% |
| Otitis Media |
2.1% |
|
| Rash |
17.5% |
| Pyrexia |
14.9% |
| Pruritus |
7.1% |
| Urticaria |
7.1% |
| Subcorneal Pustular Dermatosis |
6.5% |
| Toxic Skin Eruption |
5.8% |
| Rash Generalised |
5.2% |
| White Blood Cell Count Increased |
3.9% |
| Enterocolitis Haemorrhagic |
3.2% |
| Rash Papular |
3.2% |
| Rash Pustular |
3.2% |
| Skin Discolouration |
3.2% |
| Sudden Hearing Loss |
3.2% |
| Haematochezia |
2.6% |
| Stevens-johnson Syndrome |
2.6% |
| Tongue Discolouration |
2.6% |
| Gastric Cancer |
1.9% |
| Occult Blood |
1.9% |
| Palpitations |
1.9% |
| Stomatitis |
1.9% |
|
| Secondary |
| Helicobacter Infection |
39.1% |
| Drug Use For Unknown Indication |
9.3% |
| Otitis Media Acute |
7.3% |
| Gastric Ulcer Helicobacter |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Gastric Ulcer |
4.6% |
| Pharyngitis |
3.6% |
| Duodenal Ulcer |
3.3% |
| Cardiac Failure Congestive |
3.0% |
| Diabetes Mellitus |
3.0% |
| Hypertension |
2.6% |
| Asthma |
2.0% |
| Atrial Fibrillation |
2.0% |
| Prophylaxis |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Colitis Ulcerative |
1.3% |
| Pharyngitis Streptococcal |
1.3% |
| Streptococcal Infection |
1.3% |
| Analgesic Therapy |
1.0% |
|
| Drug Eruption |
13.8% |
| Erythema Multiforme |
13.8% |
| Liver Disorder |
12.1% |
| Sudden Hearing Loss |
8.6% |
| Drug-induced Liver Injury |
5.2% |
| Enterocolitis Haemorrhagic |
5.2% |
| White Blood Cell Count Increased |
5.2% |
| Apraxia |
3.4% |
| Cardiac Failure |
3.4% |
| Face Oedema |
3.4% |
| Gamma-glutamyltransferase Increased |
3.4% |
| Oculomucocutaneous Syndrome |
3.4% |
| Skin Disorder |
3.4% |
| Transient Ischaemic Attack |
3.4% |
| Urticaria |
3.4% |
| Acute Generalised Exanthematous Pustulosis |
1.7% |
| Anaphylactic Shock |
1.7% |
| Colitis Ischaemic |
1.7% |
| Erythema |
1.7% |
| Hepatic Function Abnormal |
1.7% |
|
| Concomitant |
| Asthma |
16.6% |
| Drug Use For Unknown Indication |
14.6% |
| Prophylaxis |
7.7% |
| Bronchitis |
7.1% |
| Pneumonia |
6.6% |
| Otitis Media |
5.9% |
| Upper Respiratory Tract Inflammation |
4.7% |
| Hypertension |
4.6% |
| Helicobacter Infection |
4.5% |
| Tonsillitis |
3.5% |
| Multiple Myeloma |
2.8% |
| Amyloidosis |
2.6% |
| Cardiac Amyloidosis |
2.6% |
| Plasma Cell Myeloma |
2.6% |
| Epilepsy |
2.4% |
| Conjunctivitis |
2.3% |
| Prophylaxis Against Dehydration |
2.3% |
| Pseudocroup |
2.3% |
| Gastric Ulcer |
2.1% |
| Breast Cancer |
1.8% |
|
| Acute Tonsillitis |
7.4% |
| Iron Deficiency Anaemia |
7.4% |
| Rhinitis |
7.4% |
| Tooth Extraction |
7.4% |
| Rash Papular |
6.2% |
| Thrombocytopenia |
6.2% |
| Drug Eruption |
4.9% |
| Enterocolitis Haemorrhagic |
4.9% |
| Nephropathy Toxic |
4.9% |
| Urinary Sediment Abnormal |
4.9% |
| Vaginal Discharge |
4.9% |
| Vertigo |
4.9% |
| Altered State Of Consciousness |
3.7% |
| Intra-uterine Death |
3.7% |
| Melaena |
3.7% |
| Pneumonia |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Vomiting |
3.7% |
| Vomiting In Pregnancy |
3.7% |
| Hepatic Function Abnormal |
2.5% |
|
